Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis

Human Immunology

Volumn 60, Issue 6, 1999, Pages 479-491

  Tassiulas, Ioannis ^a   Duncan, Steven R ^b   Centola, Michael ^a   Theofilopoulos, Argyrios N ^b   Boumpas, Dimitrios T ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alpha beta; Autoimmunity; Complementary determining region CDR3; T cell antigen receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFILTRATE; SKIN INFLAMMATION; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ARTHRITIS, PSORIATIC; BASE SEQUENCE; CLONE CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 0033025816     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00034-8     Document Type: Article

References (47)

1. Greaves M.W., Weinstein G.D. Treatment of psoriasis. N Engl J Med. 332:1995;581.
2. Boumpas DT, Tassiulas IO: Psoriatic arthritis. In Klippel JH, Weyand CM, Wortmann R (eds): Primer on Rheumatic Diseases 1997. Atlanta, GA: Arthritis Foundation, pp. 175.
3. Panayi G.S. Immunology of psoriasis and psoriatic arthritis Bailliere's Clin . Rheumatol. 8:1994;419.
4. Leung D.Y.M., Travers J.B., Giorno R., Norris D.A., Skinner R., Alelion J., Kazemi L.V., Kim M.H., Tumble A.E., Kotb M., Schlievert P.M. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 96:1995;2106.
5. Menssen A., Trommler P., Vollmer S., Schendel D., Albert E., Gurlter L., Riethmuller G., Prinz J.C. Evidence for an antigen-specific immune response in skin lesions of patients with psoriasis vulgaris. J Immunol. 155:1995;4078.
6. Chang J.C.C., Smith L.R., Froning K.J., Kurland H.H., Schwabe B.J., Blumeyer K.K., Karasek M.A., Wilkinson D.I., Farber E.M., Carol D.J., Brostoff S.W. Persistence of T-cell clones in psoriasis lesions. Arch Dermatol. 133:1997;703.
7. Christophers E, Henseler T: Psoriasis type I and type II as subsets of nonpustular psoriasis. In Roenigk HH, Maibach HI (eds): Psoriasis 1991. Marcel Dekker/New York, NY. pg.15.
8. Ragaz A., Ackerman A.B. Evolution, maturation, and regression of lesions of psoriasis. Am J Dermatopathol. 1:1979;199.
9. Lee R.E., Gaspari A.A., Lotza M.T., Chang A.E., Rosenberg S.A. Interleukin 2 and psoriasis. Arch Dermatol. 124:1998;1811.
10. Fierlbeck G., Rassner G. Treatment of psoriasis and psoriatic arthritis with interferon gamma. J Invest Dermatol. 95:(6 Suppl):1990;138S.
11. Shiohara T., Kobayashi M., Kimiaki A., Nagashima M. Psoriasis occurring predominantly on warts. Arch Dermatol. 124:1988;1816.
12. Strange P., Cooper K.D., Hansen E.R., Fisher G., Larsen J.K., Fox D., Krag C., Voorhees J.J., Baadsgaard O. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol. 101:1993;695.
13. Prinz J.C., Braun-Falco O., Meurer M., Daddona P., Reiter C., Rieber E.P., Riethmuller G. Chimeric CD4 monoclonal antibody in the treatment of generalized pustular psoriasis. Lancet. 338:1991;320.
14. Riethmuller G., Rieber E.P., Kiefersauer S., Prinz J.C., Van der Lubbe P., Meiser B., Breedvelt F., Eisenburg J., Kruger K., Deusch K., Sanders M., Reiter C. From antilymphocyte serum to therapeutic monoclonal antibodies first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease . Immunol Rev. 129:1992;81.
15. Gottlieb S.L., Gilleaudeau P., Johnson R., Estes L., Woodworth T.G., Gottlieb A.B., Krueger J.G. Response of psoriasis to a lymphocyte selective toxin (DAB382 IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med. 1:1995;442.
16. Ellis C.N., Fradin M.S., Messana J.M., Brown M.D., Siegel M.T., Hartley A.H., Rocher L.L., Wheeler S., Hamilton T.A., Parish T.G., Eliis-Madu M., Duell E., Annesley T.M., Cooper K.D., Voorhees J.J. Cyclosporine for plaque-type psoriasis results of a multidose, double-blind trial . N Engl J Med. 5:1991;277.
17. Wrone-Smith T., Nickoloff B.J. Dermal injection of immunocytes induces psoriasis. J Clin Invest. 98:1997;1878.
18. Gilhar A., David M., Ullmann Y., Berkutski T., Kalish R.S. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J Invest Dermatol. 109:1997;283.
19. Pannetier C., Even J., Kourilsky P. T -cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today. 16:1995;176.
20. Theofilopoulos A.N., Baccala R., Gonzalez-Quintal R., Kono D.H., Balderas R.S., MacPhee R., Duncan S.R., Roglic M. T-cell repertoires in health and disease. Ann NY Acad Sci. 756:1995;53.
21. Schumacher H.R., Kulka J.P. Needle biopsy of synovial membrane experience with the Parker-Pearson technique . N Engl J Med. 286:1972;416.
22. Roglic M., MacPhee R.D., Duncan S.R., Sattler F.R., Theofilopoulos A.N. T cell receptor gene repertoires and clonal expansions of CD4 cells in patients with HIV infections. Clin Exp Immunol. 107:1997;21.
23. Duncan S.R., Valentine V., Roglic M., Elias D.J., Pekny K.W., Theodore J., Kono D.H., Theofilopoulos A.N. T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. J Clin Invest. 97:1996;2642.
24. Henseler T., Christophers E. Psoriasis of early and late onset characterization of two types of psoriasis vulgaris . J Am Acad Dermatol. 13:1985;450.
25. Harris E.D. Jr. Excitement and confusion about HLA and rheumatoid arthritis. Ann Intern Med. 123:1995;232.
26. Duncan S.R., Elias D.J., Roglic M., Pekney K.W., theofilopoulos A.N. T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer. Hum Immunol. 53:1997;39.
27. Yokote R., Tokura Y., Furukawa F., Takigawa M. Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis. Arch Dermatol Res. 287:1995;443.
28. Vekony M.A., Holder J.E., Lee A.J., Horrocks C., Eperon I.C., Camp R.D. Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. J Invest Dermatol. 109:1997;5.
29. Schmitt-Egenolf M., Boehncke W., Christophers E., Stander M., Sterry W. Type I and type II psoriasis show a similar usage of T-cell receptor variable regions. J Invest Dermatol. 97:1991;1053.
30. Ahangari G., Halapi E., Tehrani M.J., Fransson J., Hammar H., Wigzell H. RT-PCR topography of chronic psoriasis skin based on analysis of T-cell receptor B variable region gene usage. Scand J Immunol. 45:1997;534.
31. Chang J.C.C., Smith L.R., Froning K.J., Schwabe B.J., Laxer J.A., Caralli L.L., Kurland H.H., Karasek M.A., Wilkinson D.I., Carlo D.J., Brostoff S.W. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V(3 and/or V(13 1 genes . Proc Natl Acad Sci USA. 91:1994;9282.
32. Lewis H.M., Bakes B.S., Bokth S., Powles A.V., Garioch J.J., Valdimarsson H., Fry L. Restricted T-cell receptor Vb gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol. 129:1993;514.
33. Boehncke W.H., Kuenzlen C., Zollner T.M., Mielke V., Sterry W. Predominant usage of distinct T-cell receptor Vb regions by epidermotropic T-cells in psoriasis. Exp Dermatol. 3:1994;161.
34. Baker B.S., Swain A.F., Fry L., Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. J Invest Dermatol. 110:1984;555.
35. Karim S.N., Murphy E.A., Sturrock R.D., Goudie R.B. T-cell clonality in synovial fluid from rheumatoid joints before and after culture in interleukin-2. Br J Rheumatol. 34:1995;232.
36. Seddom B, Saoudi A, Nicholson M, Mason D: CD4+CD8- thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur J Immunol Nov; 26:2702, 1996.
37. Herbelin A., Gombert J.M., Lepault F., Bach J.F., Chatenoud L. Mature mainstream TCR alpha beta+CD4+thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J Immunol. 161:1998;2620.
38. Jones S.M., Dixey J., Hall N.D., McHugh N.J. Expression of the cutaneous lymphocyte antigen and its counter-recepter E-selectin in the skin and joints of patients with psoriatic arthritis. Br J Rhematol. 36:1997;748.
39. Pitzalisn C., Cauli A., Pipitone N., Smith C., Barker J., Marchesoni A., Yanni G., Panayi G.S. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum. 39:1996;137.
40. Valdimarsson H., Baker B.S., Jonsdottir I., Powles A., Fry L. Psoriasis a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today. 16:1995;145.
41. Fry L. Psoriasis. Br. J. Dermatol. 119:1988;445.
42. Aoki S., Yaoti H., Kirajama Y. An elevated level of autoantibodies against 48- to 50-kd keratins in the serum of patients with psoriasis. J Invest Dermatol. 92:1989;179.
43. Baker B.S., Bokth S., Powles A., Garioch J.J., Lewis H., Valdimarsson H., Fry L. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol. 128:1993;493.
44. Simundsdottir H., Sigurgeirsson B., Troye-Blomberg M., Good M.F., Valdimarsson H., Jonsdottir I. Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins. Scand J Immunol. 45:1997;688.
45. Abe J., Forrester J., Nakahara T., Lafferty J.A., Kotzin B.L., Leung D.Y. Selective stimulation of human T cells with streptococcal erythogenic toxins A and B. J Immunol. 146:1991;3747.
46. Adorini L., Guery J.C., Rodriguez-Tarduchy G., Trembleau S. Selective immunosuppression. Immunol Today. 14:1993;285.
47. Gaur A, Fathman CG: Immunotherapuetic strategies directed at the trimolecular complex. Adv Immunol 56:219, 1994.